Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/41371
Type
ArticleCopyright
Restricted access
Embargo date
2025-12-31
Collections
Metadata
Show full item record
MILTEFOSINE AND CUTANEOUS LEISHMANIASIS
Diffuse cutaneous leishmaniasis
Disseminated leishmaniasis
Miltefosine
Mucosal leishmaniasis
Leishmaniose Cutânea
Leishmaniose Tegumentar Difusa
Antiprotozoários
Ensaios Clínicos como Assunto
Resultado do Tratamento
Affilliation
Universidade Federal da Bahia. Hospital Universitário Prof. Edgard Santos. Salvador, BA, Brasil.
Universidade de Brasília. Faculdade de Medicina. Núcleo de Medicina Tropical. Brasília, DF, Brasil / Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.
Universidade de Brasília. Faculdade de Medicina. Núcleo de Medicina Tropical. Brasília, DF, Brasil / Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.
Abstract
Purpose of review Miltefosine is a new oral treatment against leishmaniasis. The evidence about its use in New and Old World cutaneous leishmaniasis is presented and discussed. Recent findings Miltefosine is being tested with small clinical trials mainly in endemic cutaneous leishmaniasis regions of South America and Iran. Severe cutaneous leishmaniasis forms successfully treated with miltefosine are reported. Summary The use of miltefosine in cutaneous leishmaniasis has been addressed in a few clinical trials. An important advantage of this drug is its oral administration when compared with the standard parenteral drugs in the context of a large-scale use in the inner regions of the endemic countries. Miltefosine also shows activity in severe or refractory cases. However, this review points out the need for further investment on clinical research into cutaneous leishmaniasis treatment.
Keywords
Cutaneous leishmaniasisDiffuse cutaneous leishmaniasis
Disseminated leishmaniasis
Miltefosine
Mucosal leishmaniasis
DeCS
LeishmanioseLeishmaniose Cutânea
Leishmaniose Tegumentar Difusa
Antiprotozoários
Ensaios Clínicos como Assunto
Resultado do Tratamento
Share